The bidirectional relationship of thyroid disease and atrial fibrillation: Established knowledge and future considerationsΑlexandra Bekiaridou, George Giannakoulas, Anastasios D. Papanastasiou et al.|Reviews in Endocrine and Metabolic Disorders|2022Cited by 19
Prognostic implications of adherence to oral anticoagulants among patients with atrial fibrillation: Insights from MISOAC-AF trialVasiliki Patsiou, George Giannakoulas, Antonios Ziakas et al.|Journal of Cardiology|2022Cited by 10
Prognostic implications of thyroid disease in patients with atrial fibrillationGeorge Giannakoulas, Antonios Ziakas, Αναστάσιος Κάρτας et al.|Heart and Vessels|2023Cited by 10
Polypharmacy and Major Adverse Events in Atrial FibrillationChristos Tsagkaris, George Giannakoulas, Haralambos Karvounis et al.|Journal of Cardiovascular Pharmacology|2022Cited by 9
Education level predicts mortality and morbidity in hospitalised patients with atrial fibrillationVasiliki Patsiou, George Giannakoulas, Αναστάσιος Κάρτας et al.|Hellenic Journal of Cardiology|2022Cited by 6